Get the Daily Brief

All action, no filler. BioBriefs delivers the industry’s 10 must-know updates, every morning.

Latest Biotech News

Plasma LPS levels forecast mortality in acutely ill children

November 30, 2025

A multicenter study in low‑ and middle‑income countries found that plasma lipopolysaccharide (LPS) concentrations strongly predict mortality among acutely ill children. Researchers measured...

CRISPR assay flags BK and JC viruses after kidney transplant

November 30, 2025

Liu, Xu, Cao and team developed a CRISPR‑based diagnostic that detects BK and JC polyomaviruses in post‑kidney transplant patients. The assay combines sequence‑specific CRISPR detection with rapid...

Genetic evidence ties gut microbiota to human bone mass

November 30, 2025

A 2025 Nature Communications study used human genetic analyses to link gut microbiota composition with bone mass regulation. The authors leveraged population genetics and host‑microbe association...

Ferroptosis implicated in sepsis and gastric cancer — targets multiply

November 30, 2025

Two independent studies highlighted ferroptosis as a central mechanism in both sepsis pathogenesis and gastric cancer therapy resistance. One paper describes how ferroptotic cell death pathways...

Tumor immunity rewired: complement genes and TBK1/IKKε inhibition

November 30, 2025

Two mechanistic oncology studies mapped complementary ways to reshape tumor immunity. A Nature Communications paper dissected how germline and somatic variation in complement cascade genes...

FDA’s biosimilar push hits patent office

November 30, 2025

U.S. regulators announced a plan to streamline approval of biosimilars to make copycat biologics cheaper and faster to market, but industry officials warn the U.S. Patent and Trademark Office is...

ACE2 decoy receptor... Blocks mutant SARS-CoV-2

November 30, 2025

Researchers led by Lin et al. reported an engineered ACE2 decoy receptor that neutralizes multiple SARS-CoV-2 variants in vitro, including escape mutants. The work, published in the Journal of...

CRISPR assay detects BK and JC viruses in transplant patients

November 30, 2025

A CRISPR-based diagnostic developed by Liu, Xu, and Cao rapidly detects BK and JC viruses in post-kidney-transplant patients, improving surveillance timelines for polyomavirus reactivation. The...

Ferroptosis drives sepsis — IgG levels predict outcomes

November 30, 2025

New mechanistic work links ferroptosis, an iron-dependent form of cell death, to sepsis pathogenesis and organ dysfunction. The study maps lipid peroxidation and iron-handling pathways activated...

Sibiriline: first dual inhibitor of necroptosis and ferroptosis

November 30, 2025

Researchers disclosed Sibiriline, a small molecule that simultaneously inhibits necroptosis and ferroptosis in preclinical models. The compound blocks key effectors in both cell-death pathways and...

Cathepsin L dual hit... Targets tumor growth and muscle wasting

November 30, 2025

A Nature Communications study identifies Cathepsin L as a shared driver of tumor progression and cancer-associated muscle wasting. Investigators used genetic and pharmacologic inhibition to show...

Mirikizumab: single 2-ml injection bioequivalent to two 1-ml shots

November 30, 2025

A pharmacokinetic study led by Otani, Payne, and Loftus reported that a single 2‑ml subcutaneous injection of mirikizumab is bioequivalent to two separate 1‑ml injections in healthy volunteers....

mTORC1 in ILC2s... Links neurons to allergic lung inflammation

November 30, 2025

Wang, Hu, Chen and colleagues published in Nature Communications that mTORC1 signaling within group 2 innate lymphoid cells (ILC2s) mediates neuro-immune cross-talk driving allergic lung...

Complement genes: alter pancreatic cancer susceptibility and outcomes

November 30, 2025

A Nature Communications analysis dissected germline and somatic variation in complement system genes and linked them to pancreatic cancer risk, tumor microenvironment changes, and patient...

Ultrasound-triggered PANoptosis: piezoelectric nanocatalysts induce tumor death

November 30, 2025

Xu et al. reported an ultrasound-activated therapy using piezoelectric nanocatalysts that triggers PANoptosis—a combined inflammatory cell-death program—in tumor models. The approach uses focused...

FDA biosimilar plan: patent office rules threaten rollout

November 30, 2025

The FDA announced a proposal to regulate biosimilars more like small-molecule generics, aiming to halve development time and lower costs substantially. Industry leaders including Stefan Glombitza...

CRISPR test detects BK and JC viruses after kidney transplant

November 30, 2025

Researchers led by Liu, Y., Xu JS., and Cao L. developed a CRISPR-based assay to detect BK and JC polyomaviruses in kidney-transplant recipients. The team validated the assay’s specificity and...

Sibiriline: single compound blocks necroptosis and ferroptosis

November 30, 2025

Scientists reported discovery of Sibiriline, a small-molecule inhibitor that simultaneously blocks necroptosis and ferroptosis—two regulated cell‑death pathways implicated in degenerative and...

Anti‑PD‑1 plus chemotherapy rewires early hormone‑positive breast tumors

November 30, 2025

A new clinical-translational study found that combining anti‑PD‑1 immunotherapy with chemotherapy induces profound cellular reprogramming in early-stage, hormone-receptor–positive (HR+) breast...

Complement‑system genes linked to pancreatic cancer risk and outcomes

November 30, 2025

A Nature Communications study mapped genetic variation across complement cascade genes and found associations with pancreatic cancer susceptibility and prognosis. The multi-omic analysis...